The global market for Septicemia Diagnostic Testing was valued at US$ 1024 million in the year 2024 and is projected to reach a revised size of US$ 1709 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Septicemia Diagnostic Testing Market

Septicemia diagnostic testing comprises the portfolio of in vitro diagnostics used for early detection, pathogen identification, host-response/biomarker assessment (e.g., PCT, CRP, gene-expression signatures), and point-of-care triage. It spans conventional blood culture and organism identification, rapid molecular pathogen assays, multiplex panels, and host-response tests that support risk stratification and therapeutic decisions. These diagnostics are central to emergency and ICU workflows, antimicrobial stewardship, and inpatient care pathways—shortening time-to-diagnosis, guiding targeted therapy, and improving outcomes.

The septicemia diagnostic testing market presents durable, structural growth opportunities driven by policy emphasis on early recognition and standardized sepsis management, hospital investments to upgrade point-of-care and microbiology capabilities, and rapid diagnostic innovation (e.g., direct-from-blood molecular assays, multiplex pathogen panels, and host-response biomarkers). Company annual reports and investor presentations emphasize that integrated portfolios—spanning rapid screening, pathogen confirmation and therapy monitoring—can materially improve hospital workflow efficiency and support antimicrobial stewardship, making such offerings procurement priorities for large health systems. Governmental and international health guidance for early diagnostics further create a policy-driven demand window.

Key challenges persist: clinical pathways vary across institutions, so adoption of novel diagnostics requires robust clinical evidence and implementation guidance; regulatory and reimbursement regimes differ by market, complicating cross-border commercialization and pricing; and the diagnostic value chain depends on high-quality reagents, automated platforms, and interoperable IT/AI—any supply-chain or integration shortfall can hinder adoption. Corporate annual reports repeatedly note that sustained clinical validation, hospital-implementation capabilities, and regulatory strategy are essential to mitigate these risks.Hospitals and clinical customers show two concurrent trends: a firm demand for faster and earlier diagnostics that places POC and rapid molecular tests high on ED and ICU procurement lists, and an expectation that results be actionable—tests must not only be fast and accurate but directly inform antimicrobial start/stop and stratified care. Public health initiatives encourage establishment of hospital sepsis programs and quality metrics, promoting deeper integration of diagnostics into clinical pathways; clinical buyers increasingly prefer bundled solutions that combine reagents, instruments and software/services—an evolution reflected in corporate annual reports and governmental hospital program guidance. The upstream supply base for sepsis diagnostics comprises high-grade reagents, enzymes and nucleic-acid extraction kits, disposable cartridges/chips, microfluidic and fluidics components, and the electronic and software modules that power platforms. Annual reports and sell-side research highlight that reagents and single-use consumables are both margin drivers and entry barriers; the stability and quality consistency of these supplies, along with local manufacturing capability, directly affect a vendor’s competitiveness in hospital tenders. Platform vendors emphasize upstream investments into hardware–software integration (including data analytics and AI), indicating future competition will focus on integrated “reagents + instruments + digital services” capabilities. Firms that invest in R&D and supply-chain resilience to secure high-quality upstream inputs at scale will build durable competitive moats.

This report aims to provide a comprehensive presentation of the global market for Septicemia Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Septicemia Diagnostic Testing.

The Septicemia Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Septicemia Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Septicemia Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Septicemia Diagnostic Testing Market Report

Report Metric	Details
Report Name	Septicemia Diagnostic Testing Market
Accounted market size in year	US$ 1024 million
Forecasted market size in 2031	US$ 1709 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Blood Culture Blood Test Bacterial Examination Imaging Test Other
Segment by Application	Hospital Third-party Laboratory Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, Thermo Fisher Scientific, bioMérieux, Danaher, Roche, Luminex, Philips, Bruker, Immunexpress, Abbott Laboratories, T2 Biosystems, Qiagen, Siemens Healthineers, Response Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Septicemia Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Septicemia Diagnostic Testing Market growing?

Ans: The Septicemia Diagnostic Testing Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Septicemia Diagnostic Testing Market size in 2031?

Ans: The Septicemia Diagnostic Testing Market size in 2031 will be US$ 1709 million.

Who are the main players in the Septicemia Diagnostic Testing Market report?

Ans: The main players in the Septicemia Diagnostic Testing Market are BD, Thermo Fisher Scientific, bioMérieux, Danaher, Roche, Luminex, Philips, Bruker, Immunexpress, Abbott Laboratories, T2 Biosystems, Qiagen, Siemens Healthineers, Response Biomedical

What are the Application segmentation covered in the Septicemia Diagnostic Testing Market report?

Ans: The Applications covered in the Septicemia Diagnostic Testing Market report are Hospital, Third-party Laboratory, Other

What are the Type segmentation covered in the Septicemia Diagnostic Testing Market report?

Ans: The Types covered in the Septicemia Diagnostic Testing Market report are Blood Culture, Blood Test, Bacterial Examination, Imaging Test, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Septicemia Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Blood Culture

1.2.3 Blood Test

1.2.4 Bacterial Examination

1.2.5 Imaging Test

1.2.6 Other

1.3 Market by Application

1.3.1 Global Septicemia Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Third-party Laboratory

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Septicemia Diagnostic Testing Market Perspective (2020-2031)

2.2 Global Septicemia Diagnostic Testing Growth Trends by Region

2.2.1 Global Septicemia Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Septicemia Diagnostic Testing Historic Market Size by Region (2020-2025)

2.2.3 Septicemia Diagnostic Testing Forecasted Market Size by Region (2026-2031)

2.3 Septicemia Diagnostic Testing Market Dynamics

2.3.1 Septicemia Diagnostic Testing Industry Trends

2.3.2 Septicemia Diagnostic Testing Market Drivers

2.3.3 Septicemia Diagnostic Testing Market Challenges

2.3.4 Septicemia Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Septicemia Diagnostic Testing Players by Revenue

3.1.1 Global Top Septicemia Diagnostic Testing Players by Revenue (2020-2025)

3.1.2 Global Septicemia Diagnostic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Top Septicemia Diagnostic Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Septicemia Diagnostic Testing Revenue

3.4 Global Septicemia Diagnostic Testing Market Concentration Ratio

3.4.1 Global Septicemia Diagnostic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Septicemia Diagnostic Testing Revenue in 2024

3.5 Global Key Players of Septicemia Diagnostic Testing Head office and Area Served

3.6 Global Key Players of Septicemia Diagnostic Testing, Product and Application

3.7 Global Key Players of Septicemia Diagnostic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Septicemia Diagnostic Testing Breakdown Data by Type

4.1 Global Septicemia Diagnostic Testing Historic Market Size by Type (2020-2025)

4.2 Global Septicemia Diagnostic Testing Forecasted Market Size by Type (2026-2031)

5 Septicemia Diagnostic Testing Breakdown Data by Application

5.1 Global Septicemia Diagnostic Testing Historic Market Size by Application (2020-2025)

5.2 Global Septicemia Diagnostic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Septicemia Diagnostic Testing Market Size (2020-2031)

6.2 North America Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Septicemia Diagnostic Testing Market Size by Country (2020-2025)

6.4 North America Septicemia Diagnostic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Septicemia Diagnostic Testing Market Size (2020-2031)

7.2 Europe Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Septicemia Diagnostic Testing Market Size by Country (2020-2025)

7.4 Europe Septicemia Diagnostic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Septicemia Diagnostic Testing Market Size (2020-2031)

8.2 Asia-Pacific Septicemia Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Septicemia Diagnostic Testing Market Size (2020-2031)

9.2 Latin America Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Septicemia Diagnostic Testing Market Size by Country (2020-2025)

9.4 Latin America Septicemia Diagnostic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Septicemia Diagnostic Testing Market Size (2020-2031)

10.2 Middle East & Africa Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Details

11.1.2 BD Business Overview

11.1.3 BD Septicemia Diagnostic Testing Introduction

11.1.4 BD Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.1.5 BD Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Septicemia Diagnostic Testing Introduction

11.2.4 Thermo Fisher Scientific Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 bioMérieux

11.3.1 bioMérieux Company Details

11.3.2 bioMérieux Business Overview

11.3.3 bioMérieux Septicemia Diagnostic Testing Introduction

11.3.4 bioMérieux Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.3.5 bioMérieux Recent Development

11.4 Danaher

11.4.1 Danaher Company Details

11.4.2 Danaher Business Overview

11.4.3 Danaher Septicemia Diagnostic Testing Introduction

11.4.4 Danaher Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.4.5 Danaher Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Septicemia Diagnostic Testing Introduction

11.5.4 Roche Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Luminex

11.6.1 Luminex Company Details

11.6.2 Luminex Business Overview

11.6.3 Luminex Septicemia Diagnostic Testing Introduction

11.6.4 Luminex Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.6.5 Luminex Recent Development

11.7 Philips

11.7.1 Philips Company Details

11.7.2 Philips Business Overview

11.7.3 Philips Septicemia Diagnostic Testing Introduction

11.7.4 Philips Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.7.5 Philips Recent Development

11.8 Bruker

11.8.1 Bruker Company Details

11.8.2 Bruker Business Overview

11.8.3 Bruker Septicemia Diagnostic Testing Introduction

11.8.4 Bruker Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.8.5 Bruker Recent Development

11.9 Immunexpress

11.9.1 Immunexpress Company Details

11.9.2 Immunexpress Business Overview

11.9.3 Immunexpress Septicemia Diagnostic Testing Introduction

11.9.4 Immunexpress Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.9.5 Immunexpress Recent Development

11.10 Abbott Laboratories

11.10.1 Abbott Laboratories Company Details

11.10.2 Abbott Laboratories Business Overview

11.10.3 Abbott Laboratories Septicemia Diagnostic Testing Introduction

11.10.4 Abbott Laboratories Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.10.5 Abbott Laboratories Recent Development

11.11 T2 Biosystems

11.11.1 T2 Biosystems Company Details

11.11.2 T2 Biosystems Business Overview

11.11.3 T2 Biosystems Septicemia Diagnostic Testing Introduction

11.11.4 T2 Biosystems Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.11.5 T2 Biosystems Recent Development

11.12 Qiagen

11.12.1 Qiagen Company Details

11.12.2 Qiagen Business Overview

11.12.3 Qiagen Septicemia Diagnostic Testing Introduction

11.12.4 Qiagen Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.12.5 Qiagen Recent Development

11.13 Siemens Healthineers

11.13.1 Siemens Healthineers Company Details

11.13.2 Siemens Healthineers Business Overview

11.13.3 Siemens Healthineers Septicemia Diagnostic Testing Introduction

11.13.4 Siemens Healthineers Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.13.5 Siemens Healthineers Recent Development

11.14 Response Biomedical

11.14.1 Response Biomedical Company Details

11.14.2 Response Biomedical Business Overview

11.14.3 Response Biomedical Septicemia Diagnostic Testing Introduction

11.14.4 Response Biomedical Revenue in Septicemia Diagnostic Testing Business (2020-2025)

11.14.5 Response Biomedical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ICU

Thermo Fisher Scientific

List of Tables

Table 1. Global Septicemia Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Blood Culture

Table 3. Key Players of Blood Test

Table 4. Key Players of Bacterial Examination

Table 5. Key Players of Imaging Test

Table 6. Key Players of Other

Table 7. Global Septicemia Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Septicemia Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Septicemia Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Septicemia Diagnostic Testing Market Share by Region (2020-2025)

Table 11. Global Septicemia Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Septicemia Diagnostic Testing Market Share by Region (2026-2031)

Table 13. Septicemia Diagnostic Testing Market Trends

Table 14. Septicemia Diagnostic Testing Market Drivers

Table 15. Septicemia Diagnostic Testing Market Challenges

Table 16. Septicemia Diagnostic Testing Market Restraints

Table 17. Global Septicemia Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Septicemia Diagnostic Testing Market Share by Players (2020-2025)

Table 19. Global Top Septicemia Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Septicemia Diagnostic Testing as of 2024)

Table 20. Ranking of Global Top Septicemia Diagnostic Testing Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Septicemia Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Septicemia Diagnostic Testing, Headquarters and Area Served

Table 23. Global Key Players of Septicemia Diagnostic Testing, Product and Application

Table 24. Global Key Players of Septicemia Diagnostic Testing, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Septicemia Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Septicemia Diagnostic Testing Revenue Market Share by Type (2020-2025)

Table 28. Global Septicemia Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Septicemia Diagnostic Testing Revenue Market Share by Type (2026-2031)

Table 30. Global Septicemia Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Septicemia Diagnostic Testing Revenue Market Share by Application (2020-2025)

Table 32. Global Septicemia Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Septicemia Diagnostic Testing Revenue Market Share by Application (2026-2031)

Table 34. North America Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Septicemia Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 49. BD Company Details

Table 50. BD Business Overview

Table 51. BD Septicemia Diagnostic Testing Product

Table 52. BD Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 53. BD Recent Development

Table 54. Thermo Fisher Scientific Company Details

Table 55. Thermo Fisher Scientific Business Overview

Table 56. Thermo Fisher Scientific Septicemia Diagnostic Testing Product

Table 57. Thermo Fisher Scientific Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 58. Thermo Fisher Scientific Recent Development

Table 59. bioMérieux Company Details

Table 60. bioMérieux Business Overview

Table 61. bioMérieux Septicemia Diagnostic Testing Product

Table 62. bioMérieux Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 63. bioMérieux Recent Development

Table 64. Danaher Company Details

Table 65. Danaher Business Overview

Table 66. Danaher Septicemia Diagnostic Testing Product

Table 67. Danaher Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 68. Danaher Recent Development

Table 69. Roche Company Details

Table 70. Roche Business Overview

Table 71. Roche Septicemia Diagnostic Testing Product

Table 72. Roche Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 73. Roche Recent Development

Table 74. Luminex Company Details

Table 75. Luminex Business Overview

Table 76. Luminex Septicemia Diagnostic Testing Product

Table 77. Luminex Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 78. Luminex Recent Development

Table 79. Philips Company Details

Table 80. Philips Business Overview

Table 81. Philips Septicemia Diagnostic Testing Product

Table 82. Philips Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 83. Philips Recent Development

Table 84. Bruker Company Details

Table 85. Bruker Business Overview

Table 86. Bruker Septicemia Diagnostic Testing Product

Table 87. Bruker Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 88. Bruker Recent Development

Table 89. Immunexpress Company Details

Table 90. Immunexpress Business Overview

Table 91. Immunexpress Septicemia Diagnostic Testing Product

Table 92. Immunexpress Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 93. Immunexpress Recent Development

Table 94. Abbott Laboratories Company Details

Table 95. Abbott Laboratories Business Overview

Table 96. Abbott Laboratories Septicemia Diagnostic Testing Product

Table 97. Abbott Laboratories Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 98. Abbott Laboratories Recent Development

Table 99. T2 Biosystems Company Details

Table 100. T2 Biosystems Business Overview

Table 101. T2 Biosystems Septicemia Diagnostic Testing Product

Table 102. T2 Biosystems Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 103. T2 Biosystems Recent Development

Table 104. Qiagen Company Details

Table 105. Qiagen Business Overview

Table 106. Qiagen Septicemia Diagnostic Testing Product

Table 107. Qiagen Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 108. Qiagen Recent Development

Table 109. Siemens Healthineers Company Details

Table 110. Siemens Healthineers Business Overview

Table 111. Siemens Healthineers Septicemia Diagnostic Testing Product

Table 112. Siemens Healthineers Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 113. Siemens Healthineers Recent Development

Table 114. Response Biomedical Company Details

Table 115. Response Biomedical Business Overview

Table 116. Response Biomedical Septicemia Diagnostic Testing Product

Table 117. Response Biomedical Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)

Table 118. Response Biomedical Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

Table 122. Authors List of This Report

List of Figures

Figure 1. Septicemia Diagnostic Testing Picture

Figure 2. Global Septicemia Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Septicemia Diagnostic Testing Market Share by Type: 2024 VS 2031

Figure 4. Blood Culture Features

Figure 5. Blood Test Features

Figure 6. Bacterial Examination Features

Figure 7. Imaging Test Features

Figure 8. Other Features

Figure 9. Global Septicemia Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Septicemia Diagnostic Testing Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Third-party Laboratory Case Studies

Figure 13. Other Case Studies

Figure 14. Septicemia Diagnostic Testing Report Years Considered

Figure 15. Global Septicemia Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Septicemia Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Septicemia Diagnostic Testing Market Share by Region: 2024 VS 2031

Figure 18. Global Septicemia Diagnostic Testing Market Share by Players in 2024

Figure 19. Global Septicemia Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Septicemia Diagnostic Testing Revenue in 2024

Figure 21. North America Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Septicemia Diagnostic Testing Market Share by Country (2020-2031)

Figure 23. United States Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Septicemia Diagnostic Testing Market Share by Country (2020-2031)

Figure 27. Germany Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Ireland Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Septicemia Diagnostic Testing Market Share by Region (2020-2031)

Figure 35. China Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia & New Zealand Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Septicemia Diagnostic Testing Market Share by Country (2020-2031)

Figure 43. Mexico Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Septicemia Diagnostic Testing Market Share by Country (2020-2031)

Figure 47. Israel Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. BD Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 52. bioMérieux Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 53. Danaher Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 54. Roche Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 55. Luminex Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 56. Philips Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 57. Bruker Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 58. Immunexpress Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 59. Abbott Laboratories Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 60. T2 Biosystems Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 61. Qiagen Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 62. Siemens Healthineers Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 63. Response Biomedical Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions